Document is current
Any future updates will be listed below
-
Authors
Westerbergh, Frida https://orcid.org/0009-0006-3704-7357
McDougall, Lisa
Ritt, Philipp
Fricke, Julia G.
van der Meulen, Nicholas P.
Müller, Cristina
Schibli, Roger
Wild, Damian
Bernhardt, Peter
-
Funding
Funding for this research was provided by:
University of Gothenburg
- License Information
-
More Information
Article History
Received: 29 April 2025
Accepted: 11 August 2025
First Online: 28 August 2025
Declarations
:
: The BETA PLUS study was performed according to the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Northwest and Central Switzerland (01.03.2022, No: 2022 − 00162).
: Informed consent was obtained from the patient before the inclusion into the BETA PLUS study. The patient gave written informed consent to anonymously use their clinical and imaging data for publication.
: PB is a co-founder of Theravision AB. CM, NvdM, RS and DW are listed as inventors on patent application US 2023/0165981, which contains [161Tb]Tb-DOTA-LM3. PR has received honoraria for lectures for Siemens Healthineers and is currently employed at ITM.
